This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Abe, N. Articles by Atomi, Y. Search for Related Content PubMed PubMed Citation Articles by Abe, N. Articles by Atomi, Y.

Determination of High Mobility Group I(Y) Expression Level in Colorectal Neoplasias

A Potential Diagnostic Marker

First Department of Surgery [N. A., M. S., Y. A.] and Department of Clinical Pathology [T. W., H. U.], Kyorin University School of Medicine, Mitaka City, Tokyo 181-8611, Japan; Instituto Nazionale dei Tumori di Napoli, Fondazione Senatore Pascale, 80131 Naples, Italy [G. C.]; and Dipartimento di Medicina Sperimentale e Clinica, Facoltà di Medicina e Chirurgia di Catanzaro, Universita di Reggio Calabria, 88100 Catanzaro, Italy [A. F.]

High mobility group I(Y) [HMGI(Y)] proteins are architectural factors abundantly expressed during embryogenesis, and their overexpression is known to be closely associated with neoplastic transformation of cells. This study was performed to investigate whether determination of HMGI(Y) expression level could assist in (a) differential diagnosis between colorectal carcinoma, adenoma, and normal tissue and (b) determination of the prognosis of patients with colorectal cancer. To this end, HMGI(Y) expression was determined at both the protein and mRNA levels in 30 colorectal carcinomas, 26 adenomas, and 23 normal mucosa samples, and further correlations between the protein expression levels and various clinicopathological parameters, such as depth of tumor invasion, lymphatic and/or venous involvement, regional lymph node metastasis, and Dukes’ stage, were determined in 30 carcinoma cases. The expression of HMGI(Y) proteins was significantly increased in carcinoma and adenoma with severe atypia compared with that in adenoma with less atypia and normal colorectal mucosa. This increase in HMGI(Y) protein expression was found to be because of an increase in its mRNA expression by RNA in situ hybridization analysis. Clinicopathological analysis revealed that the level of HMGI(Y) protein expression was significantly correlated with parameters known to be indicative of a poor prognosis in colorectal cancer patients. These findings indicate that the determination of the HMGI(Y) protein expression level could be a potential marker for the diagnosis of colorectal neoplasias and can be of great value in predicting the prognosis of patients with colorectal cancer.

This article has been cited by other articles:

				L. Mao, K. J. Wertzler, S. C. Maloney, Z. Wang, N. S. Magnuson, and R. Reeves HMGA1 Levels Influence Mitochondrial Function and Mitochondrial DNA Repair Efficiency Mol. Cell. Biol., October 15, 2009; 29(20): 5426 - 5440. [Abstract] [Full Text] [PDF]

				J. E. Adair, S. C. Maloney, G. A. Dement, K. J. Wertzler, M. J. Smerdon, and R. Reeves High-Mobility Group A1 Proteins Inhibit Expression of Nucleotide Excision Repair Factor Xeroderma Pigmentosum Group A Cancer Res., July 1, 2007; 67(13): 6044 - 6052. [Abstract] [Full Text] [PDF]

				H. Murua Escobar, J. T. Soller, A. Richter, B. Meyer, S. Winkler, J. Bullerdiek, and I. Nolte "Best Friends" Sharing the HMGA1 Gene: Comparison of the Human and Canine HMGA1 to Orthologous Other Species J. Hered., November 1, 2005; 96(7): 777 - 781. [Abstract] [Full Text] [PDF]

				G. Giannini, F. Cerignoli, M. Mellone, I. Massimi, C. Ambrosi, C. Rinaldi, C. Dominici, L. Frati, I. Screpanti, and A. Gulino High Mobility Group A1 Is a Molecular Target for MYCN in Human Neuroblastoma Cancer Res., September 15, 2005; 65(18): 8308 - 8316. [Abstract] [Full Text] [PDF]

				G. Chiappetta, G. Botti, M. Monaco, R. Pasquinelli, F. Pentimalli, M. Di Bonito, G. D'Aiuto, M. Fedele, R. Iuliano, E. A. Palmieri, et al. HMGA1 Protein Overexpression in Human Breast Carcinomas: Correlation with ErbB2 Expression Clin. Cancer Res., November 15, 2004; 10(22): 7637 - 7644. [Abstract] [Full Text] [PDF]

				X. Chen, J. Lechago, A. Ertan, G. Ergun, R. Verm, M. Bridges, C. Johnson, K. Woods, F. Meriano, M. Chirala, et al. Expression of the High Mobility Group Proteins HMGI(Y) Correlates with Malignant Progression in Barrett's Metaplasia Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 30 - 33. [Abstract] [Full Text] [PDF]

				G. M. Pierantoni, S. Battista, F. Pentimalli, M. Fedele, R. Visone, A. Federico, M. Santoro, G. Viglietto, and A. Fusco A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas Carcinogenesis, December 1, 2003; 24(12): 1861 - 1869. [Abstract] [Full Text] [PDF]

				V. Masciullo, G. Baldassarre, F. Pentimalli, M. T. Berlingieri, A. Boccia, G. Chiappetta, J. Palazzo, G. Manfioletti, V. Giancotti, G. Viglietto, et al. HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas Carcinogenesis, July 1, 2003; 24(7): 1191 - 1198. [Abstract] [Full Text] [PDF]

				G. Baldassarre, S. Battista, B. Belletti, S. Thakur, F. Pentimalli, F. Trapasso, M. Fedele, G. Pierantoni, C. M. Croce, and A. Fusco Negative Regulation of BRCA1 Gene Expression by HMGA1 Proteins Accounts for the Reduced BRCA1 Protein Levels in Sporadic Breast Carcinoma Mol. Cell. Biol., April 1, 2003; 23(7): 2225 - 2238. [Abstract] [Full Text] [PDF]

				P. Finelli, G. M. Pierantoni, D. Giardino, M. Losa, O. Rodeschini, M. Fedele, E. Valtorta, P. Mortini, C. M. Croce, L. Larizza, et al. The High Mobility Group A2 Gene Is Amplified and Overexpressed in Human Prolactinomas Cancer Res., April 1, 2002; 62(8): 2398 - 2405. [Abstract] [Full Text] [PDF]

				N. Takaha, A. L. Hawkins, C. A. Griffin, W. B. Isaacs, and D. S. Coffey High Mobility Group Protein I(Y): A Candidate Architectural Protein for Chromosomal Rearrangements in Prostate Cancer Cells Cancer Res., February 1, 2002; 62(3): 647 - 651. [Abstract] [Full Text] [PDF]

				M. Fedele, S. Battista, G. Manfioletti, C. M. Croce, V. Giancotti, and A. Fusco Role of the high mobility group A proteins in human lipomas Carcinogenesis, October 1, 2001; 22(10): 1583 - 1591. [Abstract] [Full Text] [PDF]

				M. Fedele, G. M. Pierantoni, M. T. Berlingieri, S. Battista, G. Baldassarre, N. Munshi, M. Dentice, D. Thanos, M. Santoro, G. Viglietto, et al. Overexpression of Proteins HMGA1 Induces Cell Cycle Deregulation and Apoptosis in Normal Rat Thyroid Cells Cancer Res., June 1, 2001; 61(11): 4583 - 4590. [Abstract] [Full Text] [PDF]

				R. M. Melillo, G. M. Pierantoni, S. Scala, S. Battista, M. Fedele, A. Stella, M. C. De Biasio, G. Chiappetta, V. Fidanza, G. Condorelli, et al. Critical Role of the HMGI(Y) Proteins in Adipocytic Cell Growth and Differentiation Mol. Cell. Biol., April 1, 2001; 21(7): 2485 - 2495. [Abstract] [Full Text]

				R. Reeves, D. D. Edberg, and Y. Li Architectural Transcription Factor HMGI(Y) Promotes Tumor Progression and Mesenchymal Transition of Human Epithelial Cells Mol. Cell. Biol., January 15, 2001; 21(2): 575 - 594. [Abstract] [Full Text]

				N. Abe, T. Watanabe, T. Masaki, T. Mori, M. Sugiyama, H. Uchimura, Y. Fujioka, G. Chiappetta, A. Fusco, and Y. Atomi Pancreatic Duct Cell Carcinomas Express High Levels of High Mobility Group I(Y) Proteins Cancer Res., June 1, 2000; 60(12): 3117 - 3122. [Abstract] [Full Text]